Goldman Sachs Group Inc ARRIVENT BIOPHARMA INC Transaction History

Goldman Sachs Group Inc

  • $706 Billion
  • Q2 2025
Number of Shares
339,196
Previous 76,877 341.22%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
262,319 Added 341.22%
339,196 $0
Q1 2025

May 09, 2025
SELL
N/A
-130,392 Reduced 62.91%
76,877 $0
Q4 2024

Feb 11, 2025
BUY
N/A
134,301 Added 184.05%
207,269 $0
Q3 2024

Nov 14, 2024
BUY
N/A
72,968 New
72,968 $0
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email